ANAB
Price
$20.70
Change
+$0.09 (+0.44%)
Updated
Apr 25 closing price
Capitalization
634.8M
10 days until earnings call
CLRB
Price
$0.30
Change
-$0.01 (-3.23%)
Updated
Apr 28, 10:30 AM (EDT)
Capitalization
14.28M
9 days until earnings call
Ad is loading...

ANAB vs CLRB

Header iconANAB vs CLRB Comparison
Open Charts ANAB vs CLRBBanner chart's image
AnaptysBio
Price$20.70
Change+$0.09 (+0.44%)
Volume$306.12K
Capitalization634.8M
Cellectar Biosciences
Price$0.30
Change-$0.01 (-3.23%)
Volume$3.09K
Capitalization14.28M
ANAB vs CLRB Comparison Chart
Loading...
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANAB vs. CLRB commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANAB is a Buy and CLRB is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (ANAB: $20.70 vs. CLRB: $0.31)
Brand notoriety: ANAB and CLRB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANAB: 37% vs. CLRB: 39%
Market capitalization -- ANAB: $634.8M vs. CLRB: $14.28M
ANAB [@Biotechnology] is valued at $634.8M. CLRB’s [@Biotechnology] market capitalization is $14.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANAB’s FA Score shows that 0 FA rating(s) are green whileCLRB’s FA Score has 0 green FA rating(s).

  • ANAB’s FA Score: 0 green, 5 red.
  • CLRB’s FA Score: 0 green, 5 red.
According to our system of comparison, ANAB is a better buy in the long-term than CLRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANAB’s TA Score shows that 5 TA indicator(s) are bullish while CLRB’s TA Score has 4 bullish TA indicator(s).

  • ANAB’s TA Score: 5 bullish, 4 bearish.
  • CLRB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ANAB is a better buy in the short-term than CLRB.

Price Growth

ANAB (@Biotechnology) experienced а +0.73% price change this week, while CLRB (@Biotechnology) price change was +3.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.11%. For the same industry, the average monthly price growth was -4.17%, and the average quarterly price growth was -12.27%.

Reported Earning Dates

ANAB is expected to report earnings on Aug 11, 2025.

CLRB is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANAB($635M) has a higher market cap than CLRB($14.3M). ANAB YTD gains are higher at: 56.344 vs. CLRB (3.679). CLRB has higher annual earnings (EBITDA): -51.49M vs. ANAB (-92.74M). ANAB has more cash in the bank: 385M vs. CLRB (23.3M). CLRB has less debt than ANAB: CLRB (494K) vs ANAB (16M). ANAB has higher revenues than CLRB: ANAB (91.3M) vs CLRB (0).
ANABCLRBANAB / CLRB
Capitalization635M14.3M4,441%
EBITDA-92.74M-51.49M180%
Gain YTD56.3443.6791,532%
P/E RatioN/AN/A-
Revenue91.3M0-
Total Cash385M23.3M1,652%
Total Debt16M494K3,239%
FUNDAMENTALS RATINGS
ANAB vs CLRB: Fundamental Ratings
ANAB
CLRB
OUTLOOK RATING
1..100
2052
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
60
Fair valued
PROFIT vs RISK RATING
1..100
72100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
4365
P/E GROWTH RATING
1..100
6767
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLRB's Valuation (60) in the Biotechnology industry is in the same range as ANAB (84). This means that CLRB’s stock grew similarly to ANAB’s over the last 12 months.

ANAB's Profit vs Risk Rating (72) in the Biotechnology industry is in the same range as CLRB (100). This means that ANAB’s stock grew similarly to CLRB’s over the last 12 months.

ANAB's SMR Rating (99) in the Biotechnology industry is in the same range as CLRB (100). This means that ANAB’s stock grew similarly to CLRB’s over the last 12 months.

ANAB's Price Growth Rating (43) in the Biotechnology industry is in the same range as CLRB (65). This means that ANAB’s stock grew similarly to CLRB’s over the last 12 months.

ANAB's P/E Growth Rating (67) in the Biotechnology industry is in the same range as CLRB (67). This means that ANAB’s stock grew similarly to CLRB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANABCLRB
RSI
ODDS (%)
Bearish Trend 7 days ago
88%
Bullish Trend 7 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 7 days ago
90%
Momentum
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 7 days ago
81%
MACD
ODDS (%)
Bullish Trend 7 days ago
88%
Bullish Trend 7 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 7 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
77%
Bearish Trend 7 days ago
84%
Advances
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 15 days ago
84%
Declines
ODDS (%)
Bearish Trend 19 days ago
82%
Bearish Trend 13 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 7 days ago
85%
N/A
View a ticker or compare two or three
Ad is loading...
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA284.9525.44
+9.80%
Tesla
GME27.460.38
+1.40%
GameStop Corp
SPY550.643.95
+0.72%
SPDR® S&P 500® ETF
AAPL209.280.91
+0.44%
Apple
BTC.X93754.840000-892.085940
-0.94%
Bitcoin cryptocurrency

ANAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANAB has been loosely correlated with CLRB. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ANAB jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANAB
1D Price
Change %
ANAB100%
+0.44%
CLRB - ANAB
45%
Loosely correlated
-0.93%
ADCT - ANAB
41%
Loosely correlated
-2.21%
QTTB - ANAB
40%
Loosely correlated
+1.08%
HRMY - ANAB
39%
Loosely correlated
+2.46%
SPRY - ANAB
36%
Loosely correlated
-5.94%
More

CLRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLRB has been closely correlated with QTTB. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if CLRB jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLRB
1D Price
Change %
CLRB100%
-0.93%
QTTB - CLRB
76%
Closely correlated
+1.08%
ADCT - CLRB
47%
Loosely correlated
-2.21%
ANAB - CLRB
45%
Loosely correlated
+0.44%
IBRX - CLRB
39%
Loosely correlated
-2.97%
CELC - CLRB
38%
Loosely correlated
-2.17%
More